FDA Issues Warning Letter to Sedecal S.A.
May 28, 2025
May 28, 2025
WASHINGTON, May 28 -- The U.S. Department of Health and Human Services Food and Drug Administration issued the following warning letter to Sedecal S.A.:
* * *
To: S. Manuel Martinez Garcia, President and CEO, Sedecal S.A., C/Pelaya, 9-13 Pol Industrial Rio De Janeiro, 28110 ALGETE Madrid, Spain, mmartinez@sedecal.com, mmartinezjr@sedecal.com
Dear Mr. Martinez Garcia:
During an inspection of your firm located in Madrid, Spain on January 20, 202 . . .
* * *
To: S. Manuel Martinez Garcia, President and CEO, Sedecal S.A., C/Pelaya, 9-13 Pol Industrial Rio De Janeiro, 28110 ALGETE Madrid, Spain, mmartinez@sedecal.com, mmartinezjr@sedecal.com
Dear Mr. Martinez Garcia:
During an inspection of your firm located in Madrid, Spain on January 20, 202 . . .